Kdev Investments Ab has sold APRE and made no open-market buys since Apr 2020

KDev Investments AB is a Swedish company rather than an individual insider. Corporate records describe it as a vehicle for securities management and trading, registered on 2012-01-10, with Michael Forer listed as the contact person in business records.( It appears in KDventures’ history as part of a syndicated investment structure used for holdings in Aprea, Modus, Dilafor, and Promimic, indicating that its role has been to hold and manage venture-style life sciences investments.(

In that context, KDev Investments AB is connected to the broader KDventures/Karolinska Development ecosystem, a Nordic life sciences investment platform founded in 2003 to develop medical innovations originating from academic research, especially linked to the Karolinska Institute.( KDventures describes its mission as investing in life science companies that can turn research into differentiated products and value for patients and shareholders.(

Written by Perplexity from public sources.